Virtual Reality-Based Smoking Cessation Treatment in Patients With Schizophrenia

Schizophrenia is associated with high rates of cigarette smoking, which contributes to serious physical health problems and reduced life expectancy. Existing smoking cessation treatments have shown limited long-term success in this population. Virtual Reality-based interventions may provide a new approach for supporting smoking cessation. This study evaluated the effects of a 10-week virtual reality-based smoking cessation program in patients with schizophrenia and healthy smokers. Participants were assigned to either a virtual reality intervention group or a no-intervention control group. Smoking behavior, nicotine dependence, clinical symptoms, cognitive functioning, and quality of life were assessed before and after the intervention period.

NCT Number	NCT07618338
Lead Sponsor	Dokuz Eylul University Collaborators: The Scientific and Technological Research Council of Turkey
Conditions	Schizophrenia Disorder
Enrollment	160 participants
Start Date	2018-09-17
Primary Completion	2020-01-15 (estimated)
Study Completion	2020-01-15 (estimated)
Updated on ClinicalTrials.gov	2026-06-02